Real-World Pharmacology. Critical Thinking. Zero Room for Guesswork.
Work through 25 revised fictional medication-safety cases. Read each question, choose your response, then review the rationale and DKTP Pearl.
5 topic areas25 casesQuestion-led practice
Choose your focus
Practice cases
Case 1 of 25
Score: 0
Case 01Cardiovascular
The 0800 Digoxin Dilemma
A 79-year-old taking digoxin and furosemide reports nausea and fatigue. HR 52/min; potassium 2.9 mEq/L. Digoxin is scheduled now.
Before administering the scheduled digoxin, which action is the priority?
Why:An isolated low pulse merits verification, but the combination of symptoms, bradycardia and marked hypokalemia makes prompt assessment and escalation essential. A digoxin level may help, but should not delay action.
DKTP Pearl:The MAR has a schedule. The myocardium has an opinion.
Source category: DailyMed/FDA drug labeling (confirm product-specific current label)
Why the other options don’t fit
A. Repeating the apical pulse may verify bradycardia, but even a higher repeat rate would not explain nausea or correct potassium of 2.9 mEq/L.
C. A digoxin concentration can support evaluation, but arranging only a routine level delays action on current bradycardia, symptoms, and hypokalemia.
D. Furosemide may contribute to potassium depletion, yet rescheduling it does not resolve whether digoxin is safe to administer now.
Case 02Cardiovascular
Blood Pressure vs. Beta Blocker
A patient due for metoprolol is dizzy, BP 84/50 mmHg, HR 48/min.
Which nursing response best addresses the risk at this moment?
Why:Symptoms plus marked bradycardia/hypotension signal possible hemodynamic compromise; a transient repeat measurement alone does not establish safety.
DKTP Pearl:The medication may be due. The patient is not okay.
Source category: DailyMed/FDA drug labeling (confirm product-specific current label)
Why the other options don’t fit
A. Supine positioning and repeat readings are useful immediate assessments, but symptom improvement alone does not justify administering a rate- and pressure-lowering drug.
B. Dizziness with BP 84/50 and HR 48 is not a routine expected effect to document and defer; inadequate perfusion requires timely evaluation.
D. Asking for a lower future dose does not address the unsafe hemodynamic findings before today’s scheduled administration.
Case 03Cardiovascular
Potassium: The Plot Twist
A patient on lisinopril and spironolactone has potassium 6.1 mEq/L reported as nonhemolyzed; weakness is new.
What is the nurse’s priority action?
Why:Nonhemolyzed potassium 6.1 with new weakness raises immediate arrhythmia concern. Evaluation/treatment should not wait for routine testing, and both medicines may contribute.
DKTP Pearl:When potassium climbs, complacency should not.
Source category: DailyMed/FDA drug labeling (confirm product-specific current label)
Why the other options don’t fit
B. A verified potassium of 6.1 mEq/L plus new weakness may precede dangerous arrhythmia; waiting for routine morning labs delays urgent assessment.
C. Both spironolactone and lisinopril can increase potassium. Holding only one and administering the other without review misses the interaction and urgent risk.
D. Diet may contribute to potassium balance, but gathering a diet history cannot take priority over ECG evaluation and prompt escalation.
Case 04Cardiovascular
The Nitroglycerin Question
An ED patient with chest pain reports sildenafil use earlier today. Nitroglycerin is ordered.
Which action best addresses the medication-safety concern without delaying assessment of chest pain?
Why:PDE5 inhibitors and nitrates risk severe hypotension. A normal current BP or ECG does not remove the interaction; chest-pain evaluation continues.
DKTP Pearl:Some medication combinations should never meet.
Source category: DailyMed/FDA drug labeling (confirm product-specific current label)
Why the other options don’t fit
A. Frequent blood-pressure monitoring cannot make the nitrate–sildenafil interaction safe; profound hypotension may still occur.
B. A reassuring ECG or normal blood pressure does not eliminate the pharmacologic interaction between recent sildenafil and nitrates.
C. Further medication history matters, but persistent pain alone does not authorize giving nitroglycerin after recent sildenafil exposure.
Case 05Cardiovascular
The Diuretic and the Dizzy Patient
An older adult receiving IV furosemide has new orthostasis, low urine output, and rising creatinine. A repeat IV dose is due.
Which action best reflects safe reassessment of the diuretic order?
Why:Renal dysfunction and orthostasis call for individualized reassessment; some congested patients still need diuresis, so neither automatic administration nor permanent cessation is appropriate.
DKTP Pearl:A fluid problem is not solved by ignoring the patient.
Source category: Institutional protocol and current drug labeling
Why the other options don’t fit
A. Slower IV administration does not correct possible intravascular depletion or address reduced urine output and worsening kidney function.
C. Stopping all future diuresis until creatinine normalizes is too broad; ongoing congestion may still require carefully managed diuresis.
D. Acute kidney injury is not an acceptable automatic consequence to ignore, and a 24-hour delay may miss evolving volume or perfusion problems.
Case 06Insulin & Diabetes
Breakfast Has Left the Building
Rapid-acting mealtime insulin is scheduled but the tray is delayed and the patient is not eating. Glucose is 112 mg/dL.
What should the nurse do with the scheduled nutritional insulin?
Why:Nutritional insulin is intended to cover food intake; independently splitting or substituting insulin creates risk. Correction and basal components are separate decisions.
DKTP Pearl:Insulin is punctual. Breakfast apparently is not.
Source category: ADA Standards of Care in Diabetes 2026
Why the other options don’t fit
A. A glucose of 112 mg/dL does not replace the carbohydrate the nutritional dose is designed to cover; insulin without intake can cause hypoglycemia.
B. Correction insulin treats a qualifying elevated glucose per the prescribed scale; it is not an automatic replacement for missed meal coverage.
D. Splitting a scheduled insulin dose without an order creates dosing ambiguity and still exposes the patient to insulin before carbohydrate arrives.
Case 07Insulin & Diabetes
68 Is Not Fine
Before scheduled insulin, the patient is sweaty and shaky; point-of-care glucose is 68 mg/dL and they can safely swallow.
What is the priority nursing response?
Why:Symptomatic glucose below 70 mg/dL requires prompt treatment per protocol. Verification should not postpone treatment when signs and value agree.
DKTP Pearl:Treat the glucose reading before it writes the next chapter.
Source category: ADA Standards of Care in Diabetes 2026
Why the other options don’t fit
B. Repeating a bedside test can be reasonable if the result seems inconsistent, but giving insulin before treating symptomatic glucose of 68 mg/dL worsens risk.
C. A meal may supply carbohydrate, but waiting for the next routine check omits protocol-directed treatment and timely reassessment of hypoglycemia.
D. The pending insulin plan needs review, but waiting for a routine callback before treating a symptomatic low glucose unnecessarily delays care.
Case 08Insulin & Diabetes
NPO Does Not Mean No Basal
A patient with type 1 diabetes is NPO for surgery; all insulin is proposed to be discontinued.
Which finding in the proposed plan requires intervention?
Why:Type 1 diabetes requires basal insulin even during fasting; individual dosing and monitoring should be coordinated with the perioperative team.
DKTP Pearl:No breakfast is not a cure for type 1 diabetes.
Source category: ADA Standards of Care in Diabetes 2026
Why the other options don’t fit
A. Frequent glucose monitoring while NPO is appropriate; monitoring alone is not the unsafe proposal in this question.
B. An individualized adjustment of basal insulin may be needed perioperatively, but adjustment is different from eliminating basal coverage.
C. Correction insulin may address measured hyperglycemia, but it does not substitute for the basal insulin needed in type 1 diabetes.
Case 09Insulin & Diabetes
The Concentration Trap
A new order uses concentrated U-500 insulin. The medication room contains U-100 syringes; the dose has not been independently verified.
What is the safest action before the first U-500 dose?
Why:U-500 concentration creates a fivefold dosing-error risk when devices or markings are confused. Use a verified units-based order and compatible device under institutional procedures.
DKTP Pearl:Five times concentrated. Zero room for improvisation.
Source category: ISMP 2024 High-Alert Medications
Why the other options don’t fit
A. Mental conversion between U-500 and U-100 syringe markings is an error-prone workaround and bypasses device safeguards.
C. A second person inspecting a U-100 syringe does not make that device the appropriate delivery method for U-500 insulin.
D. Home syringe markings may reflect a historical or misunderstood practice; the clinician must verify actual units and use an appropriate device.
Case 10Insulin & Diabetes
Feeds Interrupted
A patient on scheduled insulin for continuous enteral nutrition has an unexpected tube-feed interruption.
Which action is most appropriate after unexpected tube-feed interruption?
Why:Nutrition-covering insulin can cause hypoglycemia when carbohydrate delivery stops. Monitoring and protocol-based bridging/adjustment are safer than automatic continuation or stopping basal blindly.
DKTP Pearl:Insulin did not get the memo that the tube feeds stopped.
Source category: ADA Standards of Care in Diabetes 2026
Why the other options don’t fit
A. Nutrition-covering insulin given after feeds stop may lower glucose without incoming carbohydrate, increasing hypoglycemia risk.
B. Feed interruption removes carbohydrate delivery; increasing correction insulin without a glucose-based indication compounds hypoglycemia risk.
D. Automatically stopping all basal insulin, especially in type 1 diabetes, can cause dangerous insulin deficiency and ketoacidosis.
Case 11Anticoagulants
The Black Stool Briefing
A patient taking apixaban reports new black tarry stools, dizziness, and weakness.
What should the nurse prioritize?
Why:Melena with dizziness and weakness suggests clinically significant bleeding. INR does not reliably quantify apixaban anticoagulant effect.
DKTP Pearl:Not every dark stool is a plot twist. This one could be.
Source category: DailyMed/FDA drug labeling (confirm product-specific current label)
Why the other options don’t fit
B. Melena accompanied by dizziness and weakness already warrants urgent assessment; waiting for occult-blood confirmation delays bleeding evaluation.
C. Oral fluids do not address possible anticoagulant-associated GI bleeding, and another apixaban dose may increase bleeding exposure.
D. INR is not a reliable measure of apixaban effect, and routine testing does not replace immediate assessment for bleeding.
Case 12Anticoagulants
Heparin and the Platelet Drop
On day 6 of unfractionated heparin, platelet count has fallen from 240,000 to 95,000/µL.
Which response best addresses this new finding?
Why:A platelet fall greater than 50% around days 5–10 can signal HIT even with platelets above 50,000. HIT is prothrombotic; simply lowering heparin is not adequate.
DKTP Pearl:Heparin-related trouble does not always announce itself with bleeding.
Source category: Institutional protocol and current drug labeling
Why the other options don’t fit
A. HIT is suspected from the relative platelet fall and timing, not only an absolute count below 50,000/µL; continued heparin can worsen thrombosis.
B. Reducing the rate leaves heparin exposure in place when HIT is suspected, and delaying follow-up until tomorrow is unsafe.
C. Routine prophylactic platelet transfusion is not the response to suspected HIT and may be inappropriate absent a specific indication.
Case 13Anticoagulants
Warfarin Meets Antibiotics
A stable warfarin patient is prescribed trimethoprim-sulfamethoxazole. No INR follow-up is planned.
Which action best reduces the risk of preventable harm?
Why:TMP-SMX can markedly increase anticoagulant effect through interaction with warfarin. Management requires an individualized alternative or closely monitored plan, not improvised dosing.
DKTP Pearl:Two prescriptions can be individually reasonable and collectively terrible.
Source category: DailyMed/FDA drug labeling (confirm product-specific current label)
Why the other options don’t fit
A. TMP-SMX can raise warfarin exposure and bleeding risk soon after initiation; waiting four weeks for INR follow-up is inadequate.
C. Automatically skipping one warfarin dose for every antibiotic is not an individualized, validated interaction-management strategy.
D. Arbitrarily increasing vitamin K intake can destabilize anticoagulation and does not replace prescribing review and INR monitoring.
Case 14Anticoagulants
The Head Bump
A resident on rivaroxaban falls, strikes their head, and says they feel fine.
What is the priority response after the fall?
Why:Intracranial hemorrhage may initially be occult in an anticoagulated patient. A normal INR does not rule out clinically relevant rivaroxaban effect.
DKTP Pearl:Fine is a feeling, not a CT result.
Source category: Institutional protocol and current drug labeling
Why the other options don’t fit
A. Intracranial bleeding can be initially silent after a head strike in an anticoagulated patient; observation without prompt escalation may delay needed imaging.
B. A normal INR cannot exclude significant rivaroxaban activity or intracranial injury.
D. Skipping one dose does not determine whether intracranial hemorrhage occurred and cannot replace immediate injury assessment.
Case 15Anticoagulants
The Double Anticoagulant
A discharge list includes both apixaban and warfarin, with no documented transition plan.
How should the nurse handle the discharge medication list?
Why:Overlap can be deliberate in certain transitions, but is unsafe to assume; the precise plan must be documented and verified.
DKTP Pearl:More anticoagulants does not mean more protection.
Source category: ISMP 2024 High-Alert Medications
Why the other options don’t fit
B. Taking warfarin and apixaban together without a verified transition plan can produce excessive anticoagulation and bleeding.
C. A nurse should not unilaterally discontinue warfarin; some transitions require carefully specified timing and monitoring.
D. Spacing the two drugs by 12 hours does not remove their overlapping anticoagulant effects.
Case 16Opioids & Sedatives
Pain Score 10, Respirations 7
After an opioid dose, a patient is difficult to arouse, RR 7/min, and oxygen saturation is falling. Another opioid is available PRN.
What is the nurse’s immediate priority?
Why:Respiratory rate 7 and difficult arousal are an emergency. Supporting breathing and reversing opioid effect when indicated take precedence over future dose adjustments.
DKTP Pearl:Pain matters. Breathing comes first.
Source category: FDA Drug Safety Communications
Why the other options don’t fit
A. Respirations of 7/min, declining oxygen saturation, and decreased arousability are an immediate ventilation emergency, regardless of pulse-oximeter limitations.
B. Changing a future dose and encouraging deep breaths do not reverse current potentially life-threatening opioid-induced hypoventilation.
C. A pain score is not the priority when the patient cannot maintain adequate alertness or ventilation.
Case 17Opioids & Sedatives
The Benzodiazepine Addition
An older inpatient already receiving opioid analgesia is newly ordered lorazepam and is increasingly somnolent.
What additional assessment is most important before giving lorazepam?
Why:Opioids plus benzodiazepines increase sedation and respiratory depression risk. Timing separation does not eliminate additive CNS depression.
DKTP Pearl:Two sedatives do not equal twice the relaxation.
Source category: FDA Drug Safety Communications
Why the other options don’t fit
A. Prior uneventful lorazepam use does not establish safety now, when the patient is already somnolent while receiving an opioid.
C. Anxiety-versus-pain preference does not address the immediate combined sedative burden and possible respiratory compromise.
D. Separating administration times does not eliminate lingering or additive CNS depressant effects.
Case 18Opioids & Sedatives
The Patch Is Not a Quick Fix
An opioid-naïve patient with acute postoperative pain has an order for transdermal fentanyl.
What is the safest response to the fentanyl patch order?
Why:Transdermal fentanyl is contraindicated in opioid-nontolerant patients and inappropriate for acute postoperative pain; it has delayed onset and prolonged effects.
DKTP Pearl:A patch is not an express lane to safe analgesia.
Source category: DailyMed/FDA drug labeling (confirm product-specific current label)
Why the other options don’t fit
A. Fentanyl patches have delayed delivery and are not a rescue treatment for acute postoperative pain; opioid-naïve patients face overdose risk.
B. Cutting a fentanyl patch is unsafe and does not make its use appropriate for an opioid-naïve patient.
D. Avoiding other analgesics does not eliminate the patch’s contraindication in opioid-nontolerant patients or its delayed, prolonged effects.
Case 19Opioids & Sedatives
PCA by Proxy
A patient's family member says they pressed the patient-controlled analgesia button while the patient slept.
Which action should the nurse take?
Why:PCA safety relies on patient activation as a functional protection against oversedation. Proxy activation bypasses that safeguard.
DKTP Pearl:The P stands for patient. Not proxy.
Source category: ISMP 2024 High-Alert Medications
Why the other options don’t fit
B. PCA lockout protects against overly frequent button presses, but family activation bypasses the patient’s ability to self-limit dosing as sedation develops.
C. Changing pump parameters without an order is unsafe and does not correct the underlying unauthorized proxy activation.
D. Grimacing during sleep does not authorize someone else to activate a patient-controlled medication device.
Case 20Opioids & Sedatives
Sedation Is a Vital Sign Too
A patient receiving repeated IV opioids is increasingly sleepy despite a normal pulse oximeter reading on supplemental oxygen.
Which assessment best evaluates early opioid-related deterioration?
Why:Supplemental oxygen may keep saturation normal despite hypoventilation. Sedation changes can precede respiratory arrest.
DKTP Pearl:A pretty oxygen number does not prove adequate ventilation.
Source category: ISMP 2024 High-Alert Medications
Why the other options don’t fit
A. Oxygen saturation reflects oxygenation, not ventilation; supplemental oxygen can mask rising carbon dioxide and opioid-induced hypoventilation.
B. Increasing sedation may occur before a patient can recognize or report breathing difficulty, especially after repeated IV opioids.
C. Increasing oxygen may mask desaturation without correcting decreased respiratory drive; continuing the opioid can worsen the problem.
Case 21Antibiotics
The Allergy That Needs Clarifying
An antibiotic order lists amoxicillin, while the chart says "penicillin allergy—anaphylaxis." No assessment or clarification is documented.
What is the safest next step regarding amoxicillin?
Why:Documented anaphylaxis is a high-risk immediate allergy history. Verify details and involve the prescriber/pharmacist; do not challenge or premedicate independently.
DKTP Pearl:Anaphylaxis is not a side effect to casually test.
Source category: Institutional protocol and current drug labeling
Why the other options don’t fit
A. A remote history of anaphylaxis still requires assessment; an unsupervised test dose risks provoking a serious reaction.
C. Diphenhydramine does not reliably prevent anaphylaxis and cannot make unclarified exposure to a suspected allergen safe.
D. An allergy label cannot be removed simply because a drug is preferred; appropriate history and formal evaluation are required.
Case 22Antibiotics
Vancomycin in Fast-Forward
During IV vancomycin infusion, a patient develops flushing, pruritus, and hypotension.
What is the priority action during the infusion reaction?
Why:Flushing can occur with infusion-related reactions, but hypotension requires immediate cessation and emergency evaluation. Anaphylaxis must be considered.
DKTP Pearl:The infusion pump is not a race car.
Source category: DailyMed/FDA drug labeling (confirm product-specific current label)
Why the other options don’t fit
A. Although slowing an infusion may be appropriate for a mild rate-related reaction after assessment, hypotension requires stopping and urgent evaluation.
B. Calling the reaction expected ignores present hypotension and the possibility of anaphylaxis, which require immediate action.
D. A trough concentration evaluates drug exposure, not the urgent airway or circulatory risk during an acute infusion reaction.
Case 23Antibiotics
The Creatinine Clue
A patient receiving renally cleared antibiotics develops acute kidney injury. Next doses remain unchanged.
Which intervention best addresses the change in renal function?
Why:Acute kidney injury can alter clearance and toxicity risk, but appropriate changes depend on the agent, indication and severity. An individualized plan is required.
DKTP Pearl:The kidneys have entered the chat. Read the message.
Source category: DailyMed/FDA drug labeling (confirm product-specific current label)
Why the other options don’t fit
B. Giving several unchanged doses while renal clearance deteriorates may cause drug accumulation and toxicity in renally cleared antibiotics.
C. A universal 50% reduction is not evidence-based; some drugs need interval changes, level-guided dosing, or no change depending on context.
D. Automatically stopping every antibiotic risks undertreating infection; safe adjustment depends on the agent and clinical urgency.
Case 24Antibiotics
Diarrhea Is Not Just Diarrhea
After broad-spectrum antibiotics, a patient has frequent new watery stools and abdominal cramping.
Which action is best?
Why:New significant antibiotic-associated diarrhea warrants evaluation for C. difficile and transmission precautions; not every diarrhea episode is CDI and testing follows symptom criteria.
DKTP Pearl:The antibiotic may be done. Its consequences may not be.
Source category: Institutional protocol and current drug labeling
Why the other options don’t fit
A. Immediate antimotility treatment without assessing possible C. difficile may mask symptoms and can be inappropriate in suspected infectious colitis.
B. Waiting for laboratory confirmation before applying indicated enteric/contact precautions increases potential transmission.
C. Unilaterally stopping antibiotics and delaying evaluation ignores both the need to review causative therapy and assess diarrheal illness promptly.
Case 25Antibiotics
Culture First—When Safe
A stable patient with suspected bloodstream infection has blood cultures ordered, but the antibiotic is about to infuse before collection.
What approach best balances culture yield and timely treatment?
Why:Cultures before antibiotics improve diagnostic yield when feasible, but therapy must not be delayed in a clinically unstable or time-critical patient.
DKTP Pearl:Get the evidence—without making the patient wait for rescue.
Source category: Institutional protocol and current drug labeling
Why the other options don’t fit
A. Antibiotics are not withheld until cultures become final; cultures are obtained promptly before treatment when feasible, not awaited for days.
C. Starting antibiotics first may reduce blood-culture yield if cultures could have been collected promptly without delaying urgent care.
D. Bloodstream infection can occur without fever at the moment of collection; the ordered diagnostic evaluation should not be canceled solely for that reason.
Set complete
Your results
Draft source list
References listed in the editorial draft; verify every source and relevant current recommendation before launch.
Please read this disclaimer before using the DKTP RN Pharmacology Cases.
Educational Use Only
The DKTP RN Pharmacology Cases are fictional educational materials created for nursing students and other healthcare learners. They are intended to support study and discussion only. They are not medical advice, patient-specific guidance, or instructions for diagnosing, treating, or caring for any person.
Not a Substitute for Clinical Resources or Judgment
These cases are not a substitute for current drug guides, medication package inserts, current evidence-based guidelines, other reliable clinical references, or the professional judgment of a qualified healthcare professional. They do not replace provider orders, facility policies, or applicable laws and regulations.
Medication information and clinical recommendations can change. Always verify current medication guidance using reliable, up-to-date sources before applying it. In actual care, follow your scope of practice, provider orders, facility protocols, and applicable laws and regulations. When in doubt, consult an appropriate qualified healthcare professional or supervisor.
The cases may simplify clinical situations for teaching purposes and may omit details that would matter in real patient care. NurseTalkDaily recommends clinical review of each case and verification of its supporting sources before publication. Such review does not make the cases a substitute for current clinical references or professional judgment.
Fictional Cases
All case details, including names, people, patients, facilities, and events, are fictional. Any resemblance to actual persons, living or dead, or actual events is coincidental. The cases may not represent the full complexity or circumstances of real clinical situations.
No Warranty
NurseTalkDaily makes no warranty or representation, express or implied, that the cases or related information are accurate, complete, current, error-free, or suitable for any particular purpose. Users are responsible for independently checking information before relying on it.
Limitation of Liability
To the fullest extent permitted by applicable law, NurseTalkDaily is not liable for any loss, injury, or damage arising from or related to the use of, or reliance on, these cases or related information. Nothing in this disclaimer excludes or limits liability that cannot lawfully be excluded or limited.
No NCLEX or NCSBN Affiliation
NurseTalkDaily is not affiliated with, sponsored by, or endorsed by the National Council of State Boards of Nursing (NCSBN). These cases are not an official NCLEX product and are not approved, sponsored, or endorsed by NCSBN. Any reference to NCLEX or NCSBN is for identification or educational context only.
